Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death

[1]  S. Cheng,et al.  An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation. , 2010, Biochemical pharmacology.

[2]  S. Tsao,et al.  A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. , 2010, Cancer letters.

[3]  S. Tsao,et al.  Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. , 2009, Carcinogenesis.

[4]  J. Grandis,et al.  STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro , 2009, International journal of cancer.

[5]  D. Silverman,et al.  Cancer of the Pancreas , 2009 .

[6]  M. Saegusa,et al.  EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance , 2008, International journal of cancer.

[7]  J. Inazawa,et al.  Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous‐cell carcinoma , 2008, Cancer science.

[8]  L. Trusolino,et al.  Drug development of MET inhibitors: targeting oncogene addiction and expedience , 2008, Nature Reviews Drug Discovery.

[9]  B. Foveau,et al.  The shadow of death on the MET tyrosine kinase receptor , 2008, Cell Death and Differentiation.

[10]  K. Rex,et al.  c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations* , 2008, Journal of Biological Chemistry.

[11]  S. Ishikawa,et al.  Constitutive activation of c‐Met is correlated with c‐Met overexpression and dependent on cell–matrix adhesion in lung adenocarcinoma cell lines , 2007, Cancer science.

[12]  R. Salgia,et al.  Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion , 2007, British Journal of Cancer.

[13]  J. Grandis,et al.  Antiproliferative Mechanisms of a Transcription Factor Decoy Targeting Signal Transducer and Activator of Transcription (STAT) 3: The Role of STAT1 , 2007, Molecular Pharmacology.

[14]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[15]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[16]  G. Mills,et al.  Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Siegfried,et al.  Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy , 2004, Gene Therapy.

[18]  Jian-Min Yuan,et al.  Epidemiology of nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[19]  B. Teh,et al.  Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. , 2002, Cancer research.

[20]  T. Yoshizaki,et al.  Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. , 2001, The American journal of pathology.

[21]  L. Ferrell,et al.  Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic Mice , 2001, The Journal of cell biology.

[22]  C. Cooper,et al.  Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.

[23]  J. Knowelden,et al.  Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.